Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 June 2023 | Story Boitumelo Mokheseng | Photo Supplied
Boitumelo Mokheseng
Boitumelo Mokheseng is a Presidential Youth Employment Initiative (PYEI) Intern in the Qwaqwa Campus Health and Wellness Centre.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Boitumelo Mokheseng, Presidential Youth Employment Initiative (PYEI) Intern in the Qwaqwa Campus Health and Wellness Centre, shares her UFS journey:

Q: Year of graduation from the UFS:

A: 2021.

Q: Qualification obtained from the UFS:

A: Bachelor of Administration.

Q: Date of joining the UFS as a staff member:

A: March 2023.

Q: Initial job title and current job title:

A: PYEI intern in the Qwaqwa Campus Health and Wellness Centre.

Q: How did the UFS prepare you for the professional world?

A: The University of the Free State (UFS) propelled me towards the career path I had always aspired to. The comprehensive education I received not only equipped me with the necessary skills for the workplace, but also fostered a problem-solving mindset that was ingrained in us from our undergraduate years.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: The transition from being a UFS student to a staff member has been wonderful, even though challenging, because now I get to feel the pressure that the clinic staff felt while I was a student. For instance, when visiting the clinic before, I didn’t understand why there are long queues, why we are not assisted in time; since I’m the one assisting the students with the booking systems and making sure they get to the consulting rooms, I now understand how things work.

Q: Any additional comments about your experience?

A: Working here at the UFS has been a dream come true. I am fascinated daily by meeting up with inspiring people who motivate me to do better in life, and I keep learning new things. The experience so far is good; I have acquired new skills, moved from office work and got involved in campaigns such as First Things First where I can engage more with students and meet the different stakeholders from the health department. I’m thankful for the great opportunity the university has given me to be part of it as a staff member – no longer a student.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept